Skip to content

Performance of Safety of SILKAM® Suture Material in Oral Surgery

Single Center Open-Label Post Market Clinical Follow-Up (PMCF) -Study on the Performance of Safety of SILKAM® Suture Material in Oral Surgery

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05296902
Acronym
SILKOS
Enrollment
105
Registered
2022-03-25
Start date
2022-09-21
Completion date
2023-11-16
Last updated
2024-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mucosal Wound, Teeth Impact, Tooth, Impacted, Tooth Impaction

Keywords

Tooth distraction, Removal of impacted Teeth, Oral Surgery, Dental Implant, Observational Study

Brief summary

Assessment of SILKAM® suture material in mucosal closure in oral surgery (mucosal sutures). A prospective, monocentric, single arm observational study.

Detailed description

The aim of this Non Interventional Study is to collect systematically and proactively different clinical parameters regarding safety, effectiveness, and performance of SILKAM® suture material under the daily routine clinical practice when is intended to be used for oral surgery. All patients enrolled will be prospectively followed until suture removal, which takes place approximately one week post-operatively.

Interventions

mucosal closure in oral surgery (mucosal sutures)

Sponsors

B.Braun Surgical SA
CollaboratorINDUSTRY
Aesculap AG
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing mucosal wound closure using SILKAM® as suture material in oral surgery (in the event that more than one incision is performed in the same patient, only one incision will be considered).

Exclusion criteria

* Patients taking medication that might affect wound healing * Patients having a condition that might affect wound healing. * Patients with hypersensitivity or allergy to the suture material. * Participation in another (Randomized) Clinical Trial / Clinical Study. * Non-compliance of patient (i.e. dementia).

Design outcomes

Primary

MeasureTime frameDescription
Surgical Wound Dehiscence rateuntil day of suture removal (approximately 1 week after surgery)Pathologic process consisting of a partial or complete disruption of the layers of a surgical wound.
Complication rateuntil day of suture removal (approximately 1 week after surgery)Complications rate according to the Classification of Askar as Grade 1 (Localized complication(s) accompanied by no adverse effects on the success of the surgery) and Grade 2 (Localized complication(s) accompanied by adverse effects on the success of the surgery).

Secondary

MeasureTime frameDescription
Satisfaction of the patient using the visual analogue scale (VAS 1-100)until day of suture removal (approximately 1 week after surgery)This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state 0 at one end representing completely satisfied and 100 at the opposite end representing not at all satisfied.
Complication rateuntil day of suture removal (approximately 1 week after surgery)Complications rate according to the Classification of Askar as Grade 3 (Localized or systemic complication(s) that impairs the patient's daily routine but does not require hospitalization), Grade 4 (Localized or systemic complication(s) that impairs the patient's daily routine and requires hospitalization), Grade 5 (Localized or systemic complication(s) that inflicts irreversible damage to \>1 anatomical structures), or Grade 6 (Localized or systemic complication(s) that lead to death.
Assessment of the handling of the suture materialintraoperativelyEvaluation of the handling of the suture material in five categories (Knot security, Knot run down, Knot pull tensile strength, Tissue drag, Pliability) with the 5 evaluation levels each: 'excellent', 'very good', 'good', 'satisfied' and 'poor' transferred into the evaluation scores 5, 4, 3, 2 and 1.
Wound healing assessment using the visual analogue scale (VAS 1-100)until day of suture removal (approximately 1 week after surgery)This parameter will be noted by the surgeon using the Visual Analogue Scale (VAS) which state 0 at one end representing very good wound healing and 100 at the opposite end representing very bad wound healing.
Pain assessment using the visual analogue scale (VAS 1-100)until day of suture removal (approximately 1 week after surgery)This parameter will be noted according to the Patient self assessment using the Visual Analogue Scale (VAS) which state 0 at one end representing no pain and 100 at the opposite end representing maximal pain.

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026